Stay updated on Daratumumab Combo for Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo for Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo for Newly Diagnosed Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe study history now shows that recruitment is closed and no longer seeking participants. It also adds a new revision (v3.6.0) and removes the previous revision (v3.5.5) from the record.SummaryDifference0.3%

- Check21 days agoChange DetectedA new revision tag, v3.5.5, appears in the history, replacing the previous v3.5.4, signaling a small update to the page's versioning.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision: v3.5.4 has been added as the latest entry in the Record History, replacing the previous v3.5.3. This indicates a new version of the study record history has been published.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated the site/display revision indicator in the page footer from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check99 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed in the Record History.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo for Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo for Newly Diagnosed Myeloma Clinical Trial page.